Inflawell<sup>®</sup> improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial.

Inflammopharmacology · 2022 · PMC8867130 · PMID 35201518

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Despite a decreasing trend in ESR and ALT in the BAs group, the difference was not statistically significant in comparison to the placebo group ( P = 0.164 and P = 128, respectively).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.